Allergy to ophthalmic solutions
نویسندگان
چکیده
Background Ranibizumab (Lucentis) is an antibody fragment with high binding affinity for all isoforms of Vascular Endothelial Growth Factor A (VEGF-A) and is specifically developed for intraocular use. Since its introduction in 2007 it has been administered increasingly and in our hospital approximately 1650 intravitreal injections were given in 2013. Ranibizumab is injected monthly and in most patients for a prolonged period of time. During the procedure several ophthalmic solutions are used, such as local anaesthetic, disinfection, mydriatic drugs and antibiotics.
منابع مشابه
Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models
BACKGROUND Olopatadine hydrochloride ophthalmic solutions are treated for allergic conjunctival diseases that are a selective histamine H1 receptor antagonist and an inhibitor of the release of mediators including histamine from the human mast cells. Substance P (SP) levels are increased in tears of patients with allergic conjunctivitis. However, little is known about the regulation of SP relea...
متن کاملDoubtful value of patch testing for suspected contact allergy to ophthalmic products.
Sir, Allergic contact dermatitis is the most common cause of peri-orbital eczema (1). It may be caused by allergens brought in contact with the eyelids by hand transfer (like toluene sulfonamide-formaldehyde resin in nail polishes), by airborne contact (like sesquiterpene lactones) or, most frequently, by direct application of cosmetics or topical ophthalmic medicaments. The percentage of sensi...
متن کاملA generalized reaction to thimerosal from an influenza vaccine.
BACKGROUND Thimerosal is a preservative commonly used in ophthalmic solutions, otic drops, and vaccines because of its bactericidal property. OBJECTIVE To report a case of a generalized reaction to thimerosal in a patient who received an influenza vaccine. METHODS We describe a patient who developed a generalized maculopapular eruption after receiving a thimerosal-containing influenza vacci...
متن کاملTreatment of allergic conjunctivitis with olopatadine hydrochloride eye drops
Olopatadine hydrochloride exerts a wide range of pharmacological actions such as histamine H(1) receptor antagonist action, chemical mediator suppressive action, and eosinophil infiltration suppressive action. Olopatadine hydrochloride 0.1% ophthalmic solution (Patanol((R))) was introduced to the market in Japan in October 2006. In a conjunctival allergen challenge (CAC) test, olopatadine hydro...
متن کاملChanges in Trend of Newly Prescribed Anti-Glaucoma Medications in Recent Nine Years in a Japanese Local Community
PURPOSE To investigate changes in the trend of anti-glaucoma ophthalmic solutions in 2000-2008 in a Japanese local community. MATERIALS AND METHODS The subjects of this study were patients with glaucoma who were registered in the database of the glaucoma clinic of University of Yamanashi Hospital or the database of the Association for Research in Supporting System of Chronic Diseases (ARSSCD)...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 4 شماره
صفحات -
تاریخ انتشار 2014